Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
America's Car Mart
CRMT
$20.7M
| $275K | ﹤0.01% |
+10,890
| New | +$262K |
|
|
FERAR
1602
Fifth Era Acquisition Corp I Rights
FERAR
| $274K | ﹤0.01% |
684,062
| – | – |
|
1603
SIGA Technologies
SIGA
$217M
| $273K | ﹤0.01% |
44,754
+30,651
| +217% | +$218K |
|
1604
Appian
APPN
$2.81B
| $272K | ﹤0.01% |
7,668
-163,517
| -96% | -$5.82M |
|
1605
Kyverna Therapeutics
KYTX
$538M
| $271K | ﹤0.01% |
+28,872
| New | +$214K |
|
1606
Helios Technologies
HLIO
$2.44B
| $271K | ﹤0.01% |
+5,072
| New | +$273K |
|
1607
New Oriental
EDU
$9.07B
| $271K | ﹤0.01% |
+4,926
| New | +$270K |
|
1608
IBEX
IBEX
$493M
| $270K | ﹤0.01% |
7,079
+1,861
| +36% | +$68.8K |
|
|
FBLA
1609
FB Bancorp
FBLA
$230M
| $270K | ﹤0.01% |
20,993
+1,050
| +5% | +$13K |
|
1610
Lakeland Financial Corp
LKFN
$1.48B
| $269K | ﹤0.01% |
4,708
-11,066
| -70% | -$658K |
|
1611
Pulmonx
LUNG
$105M
| $267K | ﹤0.01% |
120,693
-103,396
| -46% | -$194K |
|
1612
Ormat Technologies
ORA
$6.55B
| $266K | ﹤0.01% |
+2,411
| New | +$264K |
|
|
GOOD
1613
Gladstone Commercial Corp
GOOD
$634M
| $265K | ﹤0.01% |
24,826
-28,474
| -53% | -$316K |
|
1614
State Street SPDR S&P Homebuilders ETF
XHB
$1.41B
| $264K | ﹤0.01% |
2,562
| – | – |
|
1615
Douglas Dynamics
PLOW
$952M
| $263K | ﹤0.01% |
+8,057
| New | +$255K |
|
1616
Navient
NAVI
$892M
| $262K | ﹤0.01% |
+20,184
| New | +$251K |
|
1617
Simon Property Group
SPG
$71.2B
| $262K | ﹤0.01% |
1,417
-10,219
| -88% | -$1.86M |
|
1618
Evolution Petroleum
EPM
$126M
| $261K | ﹤0.01% |
+73,809
| New | +$311K |
|
|
VRE
1619
DELISTED
Veris Residential
VRE
| $261K | ﹤0.01% |
17,527
-31,402
| -64% | -$464K |
|
|
CTNM
1620
Contineum Therapeutics
CTNM
$637M
| $259K | ﹤0.01% |
22,673
+4,177
| +23% | +$47.7K |
|
1621
MDU Resources
MDU
$4.2B
| $258K | ﹤0.01% |
13,238
-7,440
| -36% | -$146K |
|
1622
Atlantic Union Bankshares
AUB
$5.79B
| $257K | ﹤0.01% |
+7,268
| New | +$250K |
|
1623
Howmet Aerospace
HWM
$105B
| $254K | ﹤0.01% |
1,241
-92,713
| -99% | -$18.5M |
|
1624
Amylyx Pharmaceuticals
AMLX
$4.14B
| $254K | ﹤0.01% |
21,052
-22,585
| -52% | -$307K |
|
1625
Acushnet Holdings
GOLF
$5.17B
| $254K | ﹤0.01% |
3,179
-25,049
| -89% | -$2.03M |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.